Fox Business: Eli Lilly cuts Zepbound prices in competitive weight loss drug market battle Eli Lilly on Monday announced new price cuts for its popular weight loss drug Zepbound, broadening access for patients and driving greater use of the company’s digital healthcare platform, LillyDirect ... Eli Lilly cuts Zepbound prices in competitive weight loss drug market battle Newsday: Why cheaper alternatives to weight-loss drugs like Wegovy, Zepbound will be tougher to get The days of cheaper alternatives to popular weight-loss drugs like Wegovy and Zepbound are over for some Long Islanders and are numbered for others, pharmacists and compounding industry groups say. Why cheaper alternatives to weight-loss drugs like Wegovy, Zepbound will be tougher to get In a study, people with gene variants in two genes lost slightly more weight on GLP-1 drugs, but threw up more on Zepbound.

Understanding the Context

Eli Lilly is expanding the supply and cutting the costs of its weight-loss drug Zepbound, broadening access to more patients without insurance. The company launched 7.5 mg and 10 mg vials of ...